The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Synthetic Bioactive Bone Graft Substitutes Market Research Report 2024
Synopsis
Synthetic bone graft, which is artificially produced, bulks up or extends the supply of available autograft bone (bone harvested from your own body). There are many extender biomaterials and tissues available, and their properties depend heavily on their origin and how they are processed.
Global Synthetic Bioactive Bone Graft Substitutes market is projected to reach US$ 1420.3 million in 2029, increasing from US$ 873.2 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Synthetic Bioactive Bone Graft Substitutes market research.
Primary drivers is the escalating demand for bone graft alternatives in the field of orthopedic and dental surgeries. As the global population ages, the incidence of bone-related disorders, such as osteoporosis, osteoarthritis, and spinal deformities, is increasing. Additionally, sports-related injuries and accidents contribute to the rising need for bone grafts to aid in bone regeneration and promote healing. However, the synthetic bioactive bone graft market faces certain challenges that hinder its full potential. One major challenge is the complexity of developing bioactive materials that mimic the natural composition and structure of bone. Creating materials with the right combination of minerals and proteins is essential to promote successful graft incorporation and long-term stability. In conclusion, the synthetic bioactive bone graft market is driven by the growing demand for bone graft alternatives in the face of increasing bone-related disorders and injuries. Despite the advantages they offer, the market faces challenges in developing biomimetic materials, ensuring biocompatibility, and navigating regulatory hurdles. Addressing these challenges will be crucial in unlocking the full potential of synthetic bioactive bone grafts and improving patient outcomes in orthopedic and dental procedures.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Synthetic Bioactive Bone Graft Substitutes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
Baxter
Unicare Biomedical
Bioventus
Segment by Type
Gel
Putty
Putty with Chips
Others
Segment by Application
Dental Surgery
Spine Surgery
Trauma Surgery
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Synthetic Bioactive Bone Graft Substitutes report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Synthetic bone graft, which is artificially produced, bulks up or extends the supply of available autograft bone (bone harvested from your own body). There are many extender biomaterials and tissues available, and their properties depend heavily on their origin and how they are processed.
Global Synthetic Bioactive Bone Graft Substitutes market is projected to reach US$ 1420.3 million in 2029, increasing from US$ 873.2 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Synthetic Bioactive Bone Graft Substitutes market research.
Primary drivers is the escalating demand for bone graft alternatives in the field of orthopedic and dental surgeries. As the global population ages, the incidence of bone-related disorders, such as osteoporosis, osteoarthritis, and spinal deformities, is increasing. Additionally, sports-related injuries and accidents contribute to the rising need for bone grafts to aid in bone regeneration and promote healing. However, the synthetic bioactive bone graft market faces certain challenges that hinder its full potential. One major challenge is the complexity of developing bioactive materials that mimic the natural composition and structure of bone. Creating materials with the right combination of minerals and proteins is essential to promote successful graft incorporation and long-term stability. In conclusion, the synthetic bioactive bone graft market is driven by the growing demand for bone graft alternatives in the face of increasing bone-related disorders and injuries. Despite the advantages they offer, the market faces challenges in developing biomimetic materials, ensuring biocompatibility, and navigating regulatory hurdles. Addressing these challenges will be crucial in unlocking the full potential of synthetic bioactive bone grafts and improving patient outcomes in orthopedic and dental procedures.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Synthetic Bioactive Bone Graft Substitutes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
Baxter
Unicare Biomedical
Bioventus
Segment by Type
Gel
Putty
Putty with Chips
Others
Segment by Application
Dental Surgery
Spine Surgery
Trauma Surgery
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Synthetic Bioactive Bone Graft Substitutes report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Synthetic Bioactive Bone Graft Substitutes Market Overview
1.1 Product Overview and Scope of Synthetic Bioactive Bone Graft Substitutes
1.2 Synthetic Bioactive Bone Graft Substitutes Segment by Type
1.2.1 Global Synthetic Bioactive Bone Graft Substitutes Market Value Comparison by Type (2023-2029)
1.2.2 Gel
1.2.3 Putty
1.2.4 Putty with Chips
1.2.5 Others
1.3 Synthetic Bioactive Bone Graft Substitutes Segment by Application
1.3.1 Global Synthetic Bioactive Bone Graft Substitutes Market Value by Application: (2023-2029)
1.3.2 Dental Surgery
1.3.3 Spine Surgery
1.3.4 Trauma Surgery
1.4 Global Synthetic Bioactive Bone Graft Substitutes Market Size Estimates and Forecasts
1.4.1 Global Synthetic Bioactive Bone Graft Substitutes Revenue 2018-2029
1.4.2 Global Synthetic Bioactive Bone Graft Substitutes Sales 2018-2029
1.4.3 Global Synthetic Bioactive Bone Graft Substitutes Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Synthetic Bioactive Bone Graft Substitutes Market Competition by Manufacturers
2.1 Global Synthetic Bioactive Bone Graft Substitutes Sales Market Share by Manufacturers (2018-2023)
2.2 Global Synthetic Bioactive Bone Graft Substitutes Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Synthetic Bioactive Bone Graft Substitutes Average Price by Manufacturers (2018-2023)
2.4 Global Synthetic Bioactive Bone Graft Substitutes Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Synthetic Bioactive Bone Graft Substitutes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Synthetic Bioactive Bone Graft Substitutes, Product Type & Application
2.7 Synthetic Bioactive Bone Graft Substitutes Market Competitive Situation and Trends
2.7.1 Synthetic Bioactive Bone Graft Substitutes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Synthetic Bioactive Bone Graft Substitutes Players Market Share by Revenue
2.7.3 Global Synthetic Bioactive Bone Graft Substitutes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Synthetic Bioactive Bone Graft Substitutes Retrospective Market Scenario by Region
3.1 Global Synthetic Bioactive Bone Graft Substitutes Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Synthetic Bioactive Bone Graft Substitutes Global Synthetic Bioactive Bone Graft Substitutes Sales by Region: 2018-2029
3.2.1 Global Synthetic Bioactive Bone Graft Substitutes Sales by Region: 2018-2023
3.2.2 Global Synthetic Bioactive Bone Graft Substitutes Sales by Region: 2024-2029
3.3 Global Synthetic Bioactive Bone Graft Substitutes Global Synthetic Bioactive Bone Graft Substitutes Revenue by Region: 2018-2029
3.3.1 Global Synthetic Bioactive Bone Graft Substitutes Revenue by Region: 2018-2023
3.3.2 Global Synthetic Bioactive Bone Graft Substitutes Revenue by Region: 2024-2029
3.4 North America Synthetic Bioactive Bone Graft Substitutes Market Facts & Figures by Country
3.4.1 North America Synthetic Bioactive Bone Graft Substitutes Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Synthetic Bioactive Bone Graft Substitutes Sales by Country (2018-2029)
3.4.3 North America Synthetic Bioactive Bone Graft Substitutes Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Synthetic Bioactive Bone Graft Substitutes Market Facts & Figures by Country
3.5.1 Europe Synthetic Bioactive Bone Graft Substitutes Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Synthetic Bioactive Bone Graft Substitutes Sales by Country (2018-2029)
3.5.3 Europe Synthetic Bioactive Bone Graft Substitutes Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Synthetic Bioactive Bone Graft Substitutes Market Facts & Figures by Country
3.6.1 Asia Pacific Synthetic Bioactive Bone Graft Substitutes Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Synthetic Bioactive Bone Graft Substitutes Sales by Country (2018-2029)
3.6.3 Asia Pacific Synthetic Bioactive Bone Graft Substitutes Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Synthetic Bioactive Bone Graft Substitutes Market Facts & Figures by Country
3.7.1 Latin America Synthetic Bioactive Bone Graft Substitutes Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Synthetic Bioactive Bone Graft Substitutes Sales by Country (2018-2029)
3.7.3 Latin America Synthetic Bioactive Bone Graft Substitutes Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Synthetic Bioactive Bone Graft Substitutes Market Facts & Figures by Country
3.8.1 Middle East and Africa Synthetic Bioactive Bone Graft Substitutes Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Synthetic Bioactive Bone Graft Substitutes Sales by Country (2018-2029)
3.8.3 Middle East and Africa Synthetic Bioactive Bone Graft Substitutes Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Synthetic Bioactive Bone Graft Substitutes Sales by Type (2018-2029)
4.1.1 Global Synthetic Bioactive Bone Graft Substitutes Sales by Type (2018-2023)
4.1.2 Global Synthetic Bioactive Bone Graft Substitutes Sales by Type (2024-2029)
4.1.3 Global Synthetic Bioactive Bone Graft Substitutes Sales Market Share by Type (2018-2029)
4.2 Global Synthetic Bioactive Bone Graft Substitutes Revenue by Type (2018-2029)
4.2.1 Global Synthetic Bioactive Bone Graft Substitutes Revenue by Type (2018-2023)
4.2.2 Global Synthetic Bioactive Bone Graft Substitutes Revenue by Type (2024-2029)
4.2.3 Global Synthetic Bioactive Bone Graft Substitutes Revenue Market Share by Type (2018-2029)
4.3 Global Synthetic Bioactive Bone Graft Substitutes Price by Type (2018-2029)
5 Segment by Application
5.1 Global Synthetic Bioactive Bone Graft Substitutes Sales by Application (2018-2029)
5.1.1 Global Synthetic Bioactive Bone Graft Substitutes Sales by Application (2018-2023)
5.1.2 Global Synthetic Bioactive Bone Graft Substitutes Sales by Application (2024-2029)
5.1.3 Global Synthetic Bioactive Bone Graft Substitutes Sales Market Share by Application (2018-2029)
5.2 Global Synthetic Bioactive Bone Graft Substitutes Revenue by Application (2018-2029)
5.2.1 Global Synthetic Bioactive Bone Graft Substitutes Revenue by Application (2018-2023)
5.2.2 Global Synthetic Bioactive Bone Graft Substitutes Revenue by Application (2024-2029)
5.2.3 Global Synthetic Bioactive Bone Graft Substitutes Revenue Market Share by Application (2018-2029)
5.3 Global Synthetic Bioactive Bone Graft Substitutes Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 J &J (DePuy Synthes)
6.2.1 J &J (DePuy Synthes) Corporation Information
6.2.2 J &J (DePuy Synthes) Description and Business Overview
6.2.3 J &J (DePuy Synthes) Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.2.4 J &J (DePuy Synthes) Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.2.5 J &J (DePuy Synthes) Recent Developments/Updates
6.3 SeaSpine
6.3.1 SeaSpine Corporation Information
6.3.2 SeaSpine Description and Business Overview
6.3.3 SeaSpine Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.3.4 SeaSpine Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.3.5 SeaSpine Recent Developments/Updates
6.4 Xtant Medical
6.4.1 Xtant Medical Corporation Information
6.4.2 Xtant Medical Description and Business Overview
6.4.3 Xtant Medical Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Xtant Medical Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.4.5 Xtant Medical Recent Developments/Updates
6.5 Zimmer Biomet
6.5.1 Zimmer Biomet Corporation Information
6.5.2 Zimmer Biomet Description and Business Overview
6.5.3 Zimmer Biomet Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Zimmer Biomet Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.5.5 Zimmer Biomet Recent Developments/Updates
6.6 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Stryker Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.6.5 Stryker Recent Developments/Updates
6.7 Straumann
6.6.1 Straumann Corporation Information
6.6.2 Straumann Description and Business Overview
6.6.3 Straumann Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Straumann Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.7.5 Straumann Recent Developments/Updates
6.8 Wright Medical Group
6.8.1 Wright Medical Group Corporation Information
6.8.2 Wright Medical Group Description and Business Overview
6.8.3 Wright Medical Group Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Wright Medical Group Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.8.5 Wright Medical Group Recent Developments/Updates
6.9 Hans Biomed
6.9.1 Hans Biomed Corporation Information
6.9.2 Hans Biomed Description and Business Overview
6.9.3 Hans Biomed Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hans Biomed Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.9.5 Hans Biomed Recent Developments/Updates
6.10 Arthrex
6.10.1 Arthrex Corporation Information
6.10.2 Arthrex Description and Business Overview
6.10.3 Arthrex Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Arthrex Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.10.5 Arthrex Recent Developments/Updates
6.11 Baxter
6.11.1 Baxter Corporation Information
6.11.2 Baxter Synthetic Bioactive Bone Graft Substitutes Description and Business Overview
6.11.3 Baxter Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Baxter Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.11.5 Baxter Recent Developments/Updates
6.12 Unicare Biomedical
6.12.1 Unicare Biomedical Corporation Information
6.12.2 Unicare Biomedical Synthetic Bioactive Bone Graft Substitutes Description and Business Overview
6.12.3 Unicare Biomedical Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Unicare Biomedical Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.12.5 Unicare Biomedical Recent Developments/Updates
6.13 Bioventus
6.13.1 Bioventus Corporation Information
6.13.2 Bioventus Synthetic Bioactive Bone Graft Substitutes Description and Business Overview
6.13.3 Bioventus Synthetic Bioactive Bone Graft Substitutes Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Bioventus Synthetic Bioactive Bone Graft Substitutes Product Portfolio
6.13.5 Bioventus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Synthetic Bioactive Bone Graft Substitutes Industry Chain Analysis
7.2 Synthetic Bioactive Bone Graft Substitutes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Synthetic Bioactive Bone Graft Substitutes Production Mode & Process
7.4 Synthetic Bioactive Bone Graft Substitutes Sales and Marketing
7.4.1 Synthetic Bioactive Bone Graft Substitutes Sales Channels
7.4.2 Synthetic Bioactive Bone Graft Substitutes Distributors
7.5 Synthetic Bioactive Bone Graft Substitutes Customers
8 Synthetic Bioactive Bone Graft Substitutes Market Dynamics
8.1 Synthetic Bioactive Bone Graft Substitutes Industry Trends
8.2 Synthetic Bioactive Bone Graft Substitutes Market Drivers
8.3 Synthetic Bioactive Bone Graft Substitutes Market Challenges
8.4 Synthetic Bioactive Bone Graft Substitutes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
